相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluating Outcomes Associated with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Qualitative Systematic Review
Greg T. Mah et al.
ANNALS OF PHARMACOTHERAPY (2012)
Optimal Meropenem Concentrations To Treat Multidrug-Resistant Pseudomonas aeruginosa Septic Shock
Fabio Silvio Taccone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Meta-analysis of Randomized Controlled Trials of Vancomycin for the Treatment of Patients With Gram-Positive Infections: Focus on the Study Design
Konstantinos Z. Vardakas et al.
MAYO CLINIC PROCEEDINGS (2012)
Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials
Pranita D. Tamma et al.
BMC INFECTIOUS DISEASES (2011)
Elderly Patients with Community-Acquired Pneumonia Optimal Treatment Strategies
Ulrich Thiem et al.
DRUGS & AGING (2011)
Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia
Ioannis A. Bliziotis et al.
PLOS ONE (2011)
Monotherapy or Combination Therapy? The Pseudomonas aeruginosa Conundrum
Kristi A. Traugott et al.
PHARMACOTHERAPY (2011)
The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) Study: A Multicenter Study
Raymond J. Yost et al.
PHARMACOTHERAPY (2011)
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams
Joao Goncalves-Pereira et al.
CRITICAL CARE (2011)
Comparing Outcomes of Meropenem Administration Strategies Based on Pharmacokinetic and Pharmacodynamic Principles: A Qualitative Systematic Review
Jerrold Perrott et al.
ANNALS OF PHARMACOTHERAPY (2010)
Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation
Lois S. Lee et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Treatment of Acinetobacter infections
Argyris Michalopoulos et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Comparison of the Pharmacodynamics of Biapenem in Bronchial Epithelial Lining Fluid in Healthy Volunteers Given Half-Hour and Three-Hour Intravenous Infusions
Eiki Kikuchi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Probability of Pharmacodynamic Target Attainment With Standard and Prolonged-Infusion Antibiotic Regimens for Empiric Therapy in Adults With Hospital-Acquired Pneumonia
Aryun Kim et al.
CLINICAL THERAPEUTICS (2009)
A systematic review on clinical benefits of continuous administration of β-lactam antibiotics
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections
Gita Wasan Patel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion
Leonardo Lorente et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Experience with extended-infusion meropenem in the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii
Donghao Wang
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Jason A. Roberts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
The Use of Carbapenems in the Treatment of Serious Infections
Robert P. Baughman
JOURNAL OF INTENSIVE CARE MEDICINE (2009)
Carbapenems: a potent class of antibiotics
David P. Nicolau
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Continuous infusion of β-lactam antibiotics in severe infections:: a review of its role
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Piperacillin-tazobactam:: a β-lactam/β-lactamase inhibitor combination
Alfred Gin et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
I. I. Siempos et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Piperacillin-tazobactam for Pseudomonas aeruginosa infection:: Clinical implications of an extended-infusion dosing strategy
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2007)
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial
Samir G. Sakka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection
William K. Lau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Cure of persistent, post-appendectomy Klebsiella pneumoniae septicaemia with continuous intravenous administration of meropenem
Matthew E. Falagas et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2006)
Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients
Mohammad Reza Rafati et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials
M Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli
L Lorente et al.
ANNALS OF PHARMACOTHERAPY (2006)
Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance
LR Peterson
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection
CH Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Evaluation by Monte Carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers
WA Krueger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection
S Jaruratanasirikul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials
SK Kasiakou et al.
LANCET INFECTIOUS DISEASES (2005)
Pharmacokinetics of piperacillin-tazobactam: intermittent dosing versus continuous infusion
C Buck et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials
M Paul et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis
N Safdar et al.
LANCET INFECTIOUS DISEASES (2004)
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation
TP Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Prevention of resistance: A goal for dose selection for antimicrobial agents
GL Drusano
CLINICAL INFECTIOUS DISEASES (2003)
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: A multicenter, evaluator-blind, prospective, randomized study
G Zanetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital
EM Grant et al.
PHARMACOTHERAPY (2002)
Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis
P Furno et al.
LANCET INFECTIOUS DISEASES (2002)
分享论文
